Margareta P Correia

8PUBLICATIONS
20CO-AUTHORS
Molecular targetsInnate immunityPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2025
Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targets.

Catarina Macedo-Silva, Ângela Albuquerque-Castro, Iris Carriço

|Jan 20, 2022
Downregulation of m6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.

Catarina Guimarães-Teixeira, João Lobo, Vera Miranda-Gonçalves

|Jan 17, 2022
Innate-like NKp30+CD8+ T cells armed with TCR/CAR target tumor heterogeneity.

Margareta P Correia, Ana Stojanovic, Winfried S Wels

|Aug 27, 2021
Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer.

Nair Lopes, Mariana Brütt Pacheco, Diana Soares-Fernandes

|Aug 27, 2021
Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer.

Bianca C T Flores, Margareta P Correia, José G Rodríguez

|Aug 06, 2021
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.

Mariana Brütt Pacheco, Vânia Camilo, Nair Lopes

Pageof 2